Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
BE PART OF RESEARCH logo

On International Clinical Trials Day this year, NIHR launched its ‘Be Part of Research’ campaign – aiming to provide a source of information for people to find out what research is currently taking place across the UK. The campaign raised awareness by featuring real life stories of patients who have been successfully involved in clinical research.

As part of the campaign, the Be Part of Research (formerly UKCTG) website was launched, and this continues to run as an excellent resource for anyone working or interested in clinical trials, providing details on what research is about and the many ways to get involved, as well as a listing of all studies currently taking place across the UK. The website has a search function to allow you to look through this listing for research on particular conditions or drugs, or find out where there may be studies running near you.

Again, this is a wonderful resource and OCTRU wholeheartedly recommend that you visit the website at https://bepartofresearch.nihr.ac.uk/ and take a look around!

 

 

Similar stories

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.